Bioswellable Absorbable Monofilament Sutures

Information

  • Research Project
  • 7216652
  • ApplicationId
    7216652
  • Core Project Number
    R43GM079808
  • Full Project Number
    1R43GM079808-01
  • Serial Number
    79808
  • FOA Number
    PA-06-20
  • Sub Project Id
  • Project Start Date
    4/1/2007 - 17 years ago
  • Project End Date
    9/30/2007 - 17 years ago
  • Program Officer Name
    SOMERS, SCOTT D.
  • Budget Start Date
    4/1/2007 - 17 years ago
  • Budget End Date
    9/30/2007 - 17 years ago
  • Fiscal Year
    2007
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/30/2007 - 17 years ago
Organizations

Bioswellable Absorbable Monofilament Sutures

[unreadable] DESCRIPTION (provided by applicant): Most mechanical ligations of living tissues using surgical sutures require a combination of a thread and needle combination. In most cases, the needle diameter far exceeds that of the suture, which can result in leakage of bodily fluids, including blood, through needle-created holes about implanted suture thread. Depending on the surgical site, this can lead to bleeding and infection. A few attempts have been made in earlier decades to minimize needle hole leakage without a clinically optimum solution. This prompted the pursuit of the proposed study to explore development and evaluation of a first generation of swellable sutures with a focus on the absorbable monofilament type and those for use in laparoscopy and microsurgery. Accordingly, Phase I objective is synthesis of absorbable amphiphilic polyether esters and their evaluation for use as bioswellable absorbable sutures. And Phase I plans entail (1) synthesis and characterization of several absorbable crystalline polyether esters; (2) conversion of selected copolymers to monofilaments under established conditions to provide optimum mechanical properties; (3) in vitro evaluation of non-sterile monofilaments for basic suture properties; (4) selection of candidate monofilaments for fast and delayed absorption profiles and completion of their in vivo breaking strength retention; (5) selection of two compositions to produce bioswellable, compliant monofilament sutures having fast and delayed absorption profiles for Phase II study. This entails polymer/suture development and scale-up studies and initiation of preclinical studies. Development of novel bioswellable surgical sutures will help minimize or eliminate suture- and needle-hole bleeding/leakage and associated blood loss and infection during and after surgery. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    POLY-MED, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    ANDERSON
  • Organization State
    SC
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    29625
  • Organization District
    UNITED STATES